Diclofenac Sodium
Product Images NDC 50436-2201

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Diclofenac Sodium (NDC 50436-2201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl504362201)

Diclofenac Sodium 75 mg delayed-release tablets package label showing a unit dose of 30 tablets. The label states the active ingredient strength as 75 mg, includes storage instructions, a barcode, and distributor information for Rising Pharma Holdings, Inc., East Brunswick, NJ. The label specifies prescription use (RX ONLY) and advises dispensing a medication guide to each patient.*

FDA Label Image

Logo (Risinglogo)

FDA Label Image

Structural Formula (Structural Formula)

Chemical structure of Diclofenac Sodium showing two benzene rings, one with two chlorine substitutions and the other attached to a carboxylate group with sodium. The structure includes an amide linkage between the rings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.